Nathan Rice
Stock Analyst at Piper Sandler
(3.10)
# 1,129
Out of 5,170 analysts
61
Total ratings
52.63%
Success rate
10.65%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $134.23 | +11.75% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $39.62 | +21.15% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $41.76 | +0.57% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $30.39 | +15.17% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $71.86 | +2.98% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $141.50 | -40.64% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $176.25 | +11.77% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $25.12 | -64.17% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $579.85 | -24.98% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $264.57 | -11.93% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $35.57 | +133.34% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $19.58 | -23.39% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $134.23
Upside: +11.75%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $39.62
Upside: +21.15%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $41.76
Upside: +0.57%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $30.39
Upside: +15.17%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $71.86
Upside: +2.98%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $141.50
Upside: -40.64%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $176.25
Upside: +11.77%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $25.12
Upside: -64.17%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $579.85
Upside: -24.98%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $264.57
Upside: -11.93%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $35.57
Upside: +133.34%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $19.58
Upside: -23.39%